432 related articles for article (PubMed ID: 17416863)
41. Incidence and treatment patterns of complicated bone metastases in a population-based radiotherapy program.
Tiwana MS; Barnes M; Yurkowski E; Roden K; Olson RA
Radiother Oncol; 2016 Mar; 118(3):552-6. PubMed ID: 26515410
[TBL] [Abstract][Full Text] [Related]
42. Patterns of practice in palliative radiotherapy for painful bone metastases: impact of a regional rapid access clinic on access to care.
Wu JS; Kerba M; Wong RK; Mckimmon E; Eigl B; Hagen NA
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):533-8. PubMed ID: 19910133
[TBL] [Abstract][Full Text] [Related]
43. Genetic biomarkers associated with changes in quality of life and pain following palliative radiotherapy in patients with bone metastases.
Furfari A; Wan BA; Ding K; Wong A; Zhu L; Bezjak A; Wong R; Wilson CF; DeAngelis C; Azad A; Chow E; Charames GS
Ann Palliat Med; 2017 Dec; 6(Suppl 2):S248-S256. PubMed ID: 29156910
[TBL] [Abstract][Full Text] [Related]
44. [Palliative Radiotherapy for Bone Metastases].
Nagakura H
Gan To Kagaku Ryoho; 2015 Nov; 42(11):1346-9. PubMed ID: 26602393
[TBL] [Abstract][Full Text] [Related]
45. Single versus conventional fractionated radiotherapy in the palliation of painful bone metastases.
Hamouda WE; Roshdy W; Teema M
Gulf J Oncolog; 2007 Jan; 1(1):35-41. PubMed ID: 20084712
[TBL] [Abstract][Full Text] [Related]
46. Palliative radiotherapy for prostate cancer.
Boyer MJ; Salama JK; Lee WR
Oncology (Williston Park); 2014 Apr; 28(4):306-12. PubMed ID: 24839802
[TBL] [Abstract][Full Text] [Related]
47. Genetic biomarkers associated with response to palliative radiotherapy in patients with painful bone metastases.
Furfari A; Wan BA; Ding K; Wong A; Zhu L; Bezjak A; Wong R; Wilson CF; DeAngelis C; Azad A; Chow E; Charames GS
Ann Palliat Med; 2017 Dec; 6(Suppl 2):S233-S239. PubMed ID: 29156909
[TBL] [Abstract][Full Text] [Related]
48. [Palliation of pain from bone metastases with radioactive isotopes].
Christensen TB; Petersen PM; Sørensen TH; Kamby C; Geertsen PF
Ugeskr Laeger; 2002 Jun; 164(23):3004-8. PubMed ID: 12082848
[TBL] [Abstract][Full Text] [Related]
49. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
50. Fractionation of Palliative Radiation Therapy for Bone Metastases in Ontario: Do Practice Guidelines Guide Practice?
Ashworth A; Kong W; Chow E; Mackillop WJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):31-39. PubMed ID: 26454681
[TBL] [Abstract][Full Text] [Related]
51. A review of patterns of practice and clinical guidelines in the palliative radiation treatment of uncomplicated bone metastases.
Ganesh V; Chan S; Raman S; Chow R; Hoskin P; Lam H; Wan BA; Drost L; DeAngelis C; Chow E
Radiother Oncol; 2017 Jul; 124(1):38-44. PubMed ID: 28629871
[TBL] [Abstract][Full Text] [Related]
52. Single- Versus Multiple-Fraction Radiation Therapy for Painful Bone Metastases: A Systematic Review and Meta-analysis of Nonrandomized Studies.
Saito T; Yamaguchi K; Toya R; Oya N
Adv Radiat Oncol; 2019; 4(4):706-715. PubMed ID: 31673664
[TBL] [Abstract][Full Text] [Related]
53. Assessing the effectiveness of palliative radiotherapy for painful bone metastases in low- and middle-income countries: A systematic review.
Kaganda Bomboka V; Galietta E; Donati CM; Cellini F; Rossi R; Buwenge M; Wondemagegnehu T; Deressa BT; Uddin AK; Sumon MA; Vadalà M; Maltoni M; Morganti AG
J Med Imaging Radiat Oncol; 2024 Jun; 68(4):495-504. PubMed ID: 38577713
[TBL] [Abstract][Full Text] [Related]
54. Comparison of pain-relieving effects by number of irradiations, through propensity score matching and the international consensus endpoint.
Aoki Y; Nakayama M; Nakajima K; Yamashina M; Okizaki A
Rep Pract Oncol Radiother; 2023; 28(4):506-513. PubMed ID: 37795227
[TBL] [Abstract][Full Text] [Related]
55. A definition of "uncomplicated bone metastases" based on previous bone metastases radiation trials comparing single-fraction and multi-fraction radiation therapy.
Cheon PM; Wong E; Thavarajah N; Dennis K; Lutz S; Zeng L; Chow E
J Bone Oncol; 2015 Mar; 4(1):13-7. PubMed ID: 26579484
[TBL] [Abstract][Full Text] [Related]
56. Palliative irradiation for bone metastasis--a new paradigm.
Porter AT; Fontanesi J
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1199-200. PubMed ID: 7521865
[No Abstract] [Full Text] [Related]
57. Re: Hui et al., which treatment is better?
Johnson MJ; Currow DC
J Pain Symptom Manage; 2015 Apr; 49(4):e6-7. PubMed ID: 25623925
[No Abstract] [Full Text] [Related]
58. Update on the systematic review of palliative radiotherapy trials for bone metastases.
Chow E; Zeng L; Salvo N; Dennis K; Tsao M; Lutz S
Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):112-24. PubMed ID: 22130630
[TBL] [Abstract][Full Text] [Related]
59. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.
Lutz S; Berk L; Chang E; Chow E; Hahn C; Hoskin P; Howell D; Konski A; Kachnic L; Lo S; Sahgal A; Silverman L; von Gunten C; Mendel E; Vassil A; Bruner DW; Hartsell W;
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):965-76. PubMed ID: 21277118
[TBL] [Abstract][Full Text] [Related]
60. Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14.
Howell DD; James JL; Hartsell WF; Suntharalingam M; Machtay M; Suh JH; Demas WF; Sandler HM; Kachnic LA; Berk LB
Cancer; 2013 Feb; 119(4):888-96. PubMed ID: 23165743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
